Alkermes EVP sells 2,034 shares under 10b5-1 plan
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Alkermes plc executive David Joseph Gaffin, EVP and Chief Legal Officer of Alkermes, Inc., reported an open-market sale of 2,034 Ordinary Shares at $33.20 per share. The transaction was made under a pre-arranged Rule 10b5-1 trading plan adopted by the reporting person. Following this sale, he continues to hold 231,558 Ordinary Shares directly, indicating a substantially larger remaining equity position in the company.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Ordinary Shares | 2,034 | $33.20 | $68K |
Footnotes (1)
- F1. This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 11/19/2025.
Key Figures
Key Terms
Rule 10b5-1 trading plan regulatory
open-market sale financial
Form 4 regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Alkermes (ALKS) report for David Joseph Gaffin?
Was the Alkermes (ALKS) insider sale by David Joseph Gaffin part of a trading plan?
What does the Form 4 transaction code "S" mean for Alkermes (ALKS) insider David Joseph Gaffin?
AI-generated analysis. How Rhea-AI works. Not financial advice.